Symposium 2016 Speaker Biographies
Raymond Lai, MD, FRCPC
Dr. Raymond Lai took on the role of medical director at DynaLIFE in November 2010. Dr. Lai obtained his MD and PhD degrees and completed his general pathology residency training at the University of Alberta. He then completed a hematopathology fellowship at the City of Hope National Medical Center in Duarte, California. Dr. Lai also runs an active research laboratory at the University of Alberta.
Will Chen, MD, FRCPC
Dr. Chen obtained his medical degree at McGill University, followed by anatomical pathology residency training at University of Toronto and hematopathology fellowship at ARUP Laboratories/University of Utah. He is dual certified in anatomic pathology by the Royal College of Physicians of Canada and the American Board of Pathology, and also holds American Board certification in hematopathology. His practice interests are in general surgical pathology and hematopathology (lymphoma/bone marrows/flow cytometry). In addition to consulting for DynaLIFE, he provides hematopathology consultation services to northern Alberta at the Cross Cancer Institute.
Gwen Clarke, MD, FRCPC
Dr. Clarke is a hematopathologist and transfusion medicine physician. She works at Canadian Blood Services as the associate medical director for clinical services. She is a clinical professor in the department of laboratory medicine and pathology at the University of Alberta. She serves as a medical consultant with the College of Physicians and Surgeons of Alberta proficiency testing program (ALQEP). Dr. Clarke’s particular professional interests include: perinatal transfusion medicine, immunohematology, quality assurance and medical education.
Dylan Thomas, PhD
Dr. Dylan Thomas obtained a PhD in pharmaceutical sciences from the University of British Columbia in 2013. His work involved characterizing the enzyme mechanism and kinetics of protein arginine N-methyltransferases, a family of enzymes important for epigenetic regulation. He was awarded a university fellowship to complete this work. Dr. Thomas then completed a postdoctoral fellowship in clinical chemistry at the University of Toronto. During this time, he was involved in both CALIPER reference range transference, city wide education on POCT for drugs of abuse and implementing therapeutic drug monitoring for mitotane. He also helped develop laboratory information system tools for processing interval calculations. Areas of clinical and research expertise: Mass spectrometry, data modeling, method development, hemoglobinopathies and pediatric reference intervals.
Natalia Solomon, MD, FRCPC
Dr. Solomon completed a fellowship in pediatric infectious diseases in 2005 and residency training in medical microbiology in 2009 at the University of Alberta. After graduation she worked as a full time medical microbiologist at the Provincial Laboratory for Public Health and the University of Alberta Hospitals microbiology laboratory, where she gained experience in acute care microbiology, community microbiology, virology, infection control and public health aspects of laboratory services.
Dr. Solomon has a strong interest in medical education. She served for four years as the program director for the medical microbiology residency program at the University of Alberta and she continues to be involved with undergraduate and postgraduate medical education.
Mathew Estey, PhD
Dr. Mathew Estey obtained a PhD in biochemistry and cell biology from the University of Toronto in 2011. His research focused on elucidating the function of a protein called septin9, which has been implicated in certain types of cancer. In recognition of this work, he received the Hospital for Sick Children’s Exceptional Trainee Award for research excellence and exemplary characteristics. Dr. Estey then completed a postdoctoral fellowship in clinical chemistry, also at the University of Toronto. During this time, he was the lead investigator of the CALIPER transference study, a Canada-wide initiative to determine age and gender specific pediatric reference intervals. Areas of clinical and research expertise: Celiac disease, cobalt/chromium toxicity, endrocrinology, hemoglobinopathies and pediatric reference intervals.
Todd McMullen, MD, PhD, FRCSC, FACS
Dr. Todd McMullen is the division director for surgical oncology at the Cross Cancer Institute and an associate professor of surgery and oncology at the University of Alberta. Dr. McMullen trained as an endocrine surgeon at the world-renowned Endocrine Surgery Centre in Sydney, Australia. Specializing in thyroid and parathyroid surgery he also has a laboratory studying mechanisms of lymph node metastases for thyroid carcinoma. His primary academic interests include developing new markers for predicting metastatic disease in thyroid cancer and synoptic reporting pathways to help surgeons track and report their outcomes in real time.
Tawny Hung, MD, FRCPC
Dr. Tawny Hung is an American board-certified dermatopathologist who received her training in dermatopathology at the University of California, Los Angeles. She has over 20 publications in the literature, with most of her research focused in dermatopathology. She teaches in the departments of pathology and dermatology at the University of Alberta, and is a dermatopathology consultant with DynaLIFE.
Stephen Shafran, MD, FRCPC, FIDSA, FACP
Stephen D. Shafran received his MD from the University of Toronto. He trained in internal medicine at the University of Toronto and in infectious diseases at the University of British Columbia. After an initial academic appointment at the University of Saskatchewan from 1986-1989, he moved to the University of Alberta in 1989 and was promoted to professor in 1998. He has held the positions of director of the infectious diseases training program, director of undergraduate education for the department of medicine and director of the division of infectious diseases (1998-2008, 2014-2015). He has served the Canadian Infectious Disease Society (precursor of AMMI) in several capacities, including as president. He has received teaching awards from both the University of Saskatchewan and the University of Alberta. He received an award from the American Society for Microbiology for the best abstract in the subject of antiviral therapy. His research focuses on clinical trials of antiviral agents and viral vaccines in adults. He has over 100 publications and over 100 abstracts. His outpatient practice is focused primarily on HIV, HCV, and HBV infections. He also provides hepatitis and HIV care to inmates in two federal prisons in northern Alberta and is a consultant to Correctional Services Canada.